Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 524

1.

Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.

Wei J, Waithman J, Lata R, Mifsud NA, Cebon J, Kay T, Smyth MJ, Sadler AJ, Chen W.

J Immunol. 2010 Nov 15;185(10):6013-22. doi: 10.4049/jimmunol.1002129. Epub 2010 Oct 18.

2.

Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.

Bochtler P, Kröger A, Schirmbeck R, Reimann J.

J Immunol. 2008 Aug 1;181(3):1633-43.

3.

IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.

Blachère NE, Morris HK, Braun D, Saklani H, Di Santo JP, Darnell RB, Albert ML.

J Immunol. 2006 Jun 15;176(12):7288-300.

4.

Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.

Lorenzi S, Mattei F, Sistigu A, Bracci L, Spadaro F, Sanchez M, Spada M, Belardelli F, Gabriele L, Schiavoni G.

J Immunol. 2011 May 1;186(9):5142-50. doi: 10.4049/jimmunol.1004163. Epub 2011 Mar 25.

5.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
6.

Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.

Klotz L, Hucke S, Thimm D, Classen S, Gaarz A, Schultze J, Edenhofer F, Kurts C, Klockgether T, Limmer A, Knolle P, Burgdorf S.

J Immunol. 2009 Jul 1;183(1):129-36. doi: 10.4049/jimmunol.0804260. Epub 2009 Jun 17.

7.
8.

CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.

Lindsay RW, Darrah PA, Quinn KM, Wille-Reece U, Mattei LM, Iwasaki A, Kasturi SP, Pulendran B, Gall JG, Spies AG, Seder RA.

J Immunol. 2010 Aug 1;185(3):1513-21. doi: 10.4049/jimmunol.1000338. Epub 2010 Jul 7.

9.

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

Mouriès J, Moron G, Schlecht G, Escriou N, Dadaglio G, Leclerc C.

Blood. 2008 Nov 1;112(9):3713-22. doi: 10.1182/blood-2008-03-146290. Epub 2008 Aug 12.

10.

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

Tosi D, Valenti R, Cova A, Sovena G, Huber V, Pilla L, Arienti F, Belardelli F, Parmiani G, Rivoltini L.

J Immunol. 2004 May 1;172(9):5363-70.

11.

Optimal conditions required for influenza A infection-enhanced cross-priming of CD8⁺ T cells specific to cell-associated antigens.

Wei J, Waithman J, Xiao K, Oveissi S, Chen W.

Immunol Cell Biol. 2013 Oct;91(9):576-82. doi: 10.1038/icb.2013.46. Epub 2013 Sep 10.

PMID:
24018533
12.

Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo.

Asano J, Tada H, Onai N, Sato T, Horie Y, Fujimoto Y, Fukase K, Suzuki A, Mak TW, Ohteki T.

J Immunol. 2010 Jan 15;184(2):736-45. doi: 10.4049/jimmunol.0900726. Epub 2009 Dec 11.

13.

Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.

Kim S, Shen T, Min B.

J Immunol. 2009 Sep 1;183(5):3033-9. doi: 10.4049/jimmunol.0900332. Epub 2009 Aug 10.

14.

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, Borrow P, Tough DF.

Nat Immunol. 2003 Oct;4(10):1009-15. Epub 2003 Sep 21.

PMID:
14502286
15.

Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice.

Johannsen A, Genolet R, Legler DF, Luther SA, Luescher IF.

J Immunol. 2010 Sep 15;185(6):3445-55. doi: 10.4049/jimmunol.1001397. Epub 2010 Aug 23.

16.

Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.

Oizumi S, Strbo N, Pahwa S, Deyev V, Podack ER.

J Immunol. 2007 Aug 15;179(4):2310-7.

17.

Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes.

Reinicke AT, Omilusik KD, Basha G, Jefferies WA.

PLoS One. 2009 Oct 6;4(10):e7210. doi: 10.1371/journal.pone.0007210.

18.

Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity.

Wells JW, Cowled CJ, Farzaneh F, Noble A.

J Immunol. 2008 Sep 1;181(5):3422-31.

20.

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Schulz O, Diebold SS, Chen M, Näslund TI, Nolte MA, Alexopoulou L, Azuma YT, Flavell RA, Liljeström P, Reis e Sousa C.

Nature. 2005 Feb 24;433(7028):887-92. Epub 2005 Feb 13.

Supplemental Content

Support Center